Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10665916rdf:typepubmed:Citationlld:pubmed
pubmed-article:10665916lifeskim:mentionsumls-concept:C0019693lld:lifeskim
pubmed-article:10665916lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:10665916lifeskim:mentionsumls-concept:C0205462lld:lifeskim
pubmed-article:10665916lifeskim:mentionsumls-concept:C0524910lld:lifeskim
pubmed-article:10665916lifeskim:mentionsumls-concept:C0007328lld:lifeskim
pubmed-article:10665916lifeskim:mentionsumls-concept:C2348519lld:lifeskim
pubmed-article:10665916pubmed:issue1lld:pubmed
pubmed-article:10665916pubmed:dateCreated2000-2-17lld:pubmed
pubmed-article:10665916pubmed:abstractTextHepatitis C virus (HCV) is frequently encountered in human immunodeficiency virus (HIV)-infected patients because of common routes of transmission. Previous studies suggested that HIV infection impaired the natural course of chronic hepatitis C, with a more rapid progression to cirrhosis. However, these studies did not assess the HIV infection impact on chronic hepatitis C by taking into account the risk factors for liver fibrosis progression: alcohol, sex, age at the contamination, and duration of HCV infection. We studied liver biopsy specimens of 2 groups of 58 patients that were infected by both HCV and HIV or by HCV alone. The 2 groups were matched according those risk factors, and liver biopsy responses were evaluated with the METAVIR items. The METAVIR activity was higher in HIV-positive than HIV-negative patients. Cirrhosis was more frequent: (1) in HIV-positive patients with CD4 < or = 200 cells/microL (45%) than in HIV-negative patients (10%) (P = .003), (2) in HIV-positive patients with CD4 < or = 200 cells/microL (45%) than in HIV-positive patients with CD4 > 200 cells/microL (17%) (P = .04). These differences, which were linked to HIV status, might be related to the enhanced HCV replication during HIV infection or other immune mechanisms that need further studies.lld:pubmed
pubmed-article:10665916pubmed:languageenglld:pubmed
pubmed-article:10665916pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10665916pubmed:citationSubsetIMlld:pubmed
pubmed-article:10665916pubmed:statusMEDLINElld:pubmed
pubmed-article:10665916pubmed:monthJanlld:pubmed
pubmed-article:10665916pubmed:issn0046-8177lld:pubmed
pubmed-article:10665916pubmed:authorpubmed-author:OpolonPPlld:pubmed
pubmed-article:10665916pubmed:authorpubmed-author:PoynardTTlld:pubmed
pubmed-article:10665916pubmed:authorpubmed-author:Le...lld:pubmed
pubmed-article:10665916pubmed:authorpubmed-author:CharlotteFFlld:pubmed
pubmed-article:10665916pubmed:authorpubmed-author:BenhamouYYlld:pubmed
pubmed-article:10665916pubmed:authorpubmed-author:AlloreMMlld:pubmed
pubmed-article:10665916pubmed:issnTypePrintlld:pubmed
pubmed-article:10665916pubmed:volume31lld:pubmed
pubmed-article:10665916pubmed:ownerNLMlld:pubmed
pubmed-article:10665916pubmed:authorsCompleteYlld:pubmed
pubmed-article:10665916pubmed:pagination69-74lld:pubmed
pubmed-article:10665916pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10665916pubmed:meshHeadingpubmed-meshheading:10665916...lld:pubmed
pubmed-article:10665916pubmed:meshHeadingpubmed-meshheading:10665916...lld:pubmed
pubmed-article:10665916pubmed:meshHeadingpubmed-meshheading:10665916...lld:pubmed
pubmed-article:10665916pubmed:meshHeadingpubmed-meshheading:10665916...lld:pubmed
pubmed-article:10665916pubmed:meshHeadingpubmed-meshheading:10665916...lld:pubmed
pubmed-article:10665916pubmed:meshHeadingpubmed-meshheading:10665916...lld:pubmed
pubmed-article:10665916pubmed:meshHeadingpubmed-meshheading:10665916...lld:pubmed
pubmed-article:10665916pubmed:meshHeadingpubmed-meshheading:10665916...lld:pubmed
pubmed-article:10665916pubmed:meshHeadingpubmed-meshheading:10665916...lld:pubmed
pubmed-article:10665916pubmed:meshHeadingpubmed-meshheading:10665916...lld:pubmed
pubmed-article:10665916pubmed:meshHeadingpubmed-meshheading:10665916...lld:pubmed
pubmed-article:10665916pubmed:year2000lld:pubmed
pubmed-article:10665916pubmed:articleTitleImpact of human immunodeficiency virus infection on the histological features of chronic hepatitis C: a case-control study. The MULTIVIRC group.lld:pubmed
pubmed-article:10665916pubmed:affiliationService d'Anatomie et de Cytologie Pathologiques, Groupe Hospitalier Pitié-Salpétrière, Paris, France.lld:pubmed
pubmed-article:10665916pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10665916pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10665916lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10665916lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10665916lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10665916lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10665916lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10665916lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10665916lld:pubmed